Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-22-023494

Chief Scientific Officer sold 7,950 shares at $60.00 ($477,000)

  • Chief Scientific Officer acquired 7,950 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lachey Jennifer · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-04 Exercise or conversion : show line 1 in the form +7,950 $0.30 $2,385 93,650 D
2022-04-04 Sale : show line 2 in the form −7,950 $60.00 $477,000 85,700 D
Open-market sales · 7,950 sh · avg $60.00 · $477,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-04 Exercise or conversion : show line 3 in the form of Shares Employee Stock Option (right to buy) −7,950 76,705 D
Loading xslF345X03/doc4.xml…